Table of Contents Author Guidelines Submit a Manuscript
Journal of Oncology
Volume 2014, Article ID 236482, 7 pages
http://dx.doi.org/10.1155/2014/236482
Research Article

A Case-Control Study of the Role of Human Papillomavirus in Oesophageal Squamous Cell Carcinoma in Australia

1School of Public Health and Community Medicine, The University of New South Wales, Kensington, NSW 2052, Australia
2Department of Medicine, St. Vincent's Hospital Clinical School, The University of New South Wales, Kensington, NSW 2052, Australia
3UNSW Medicine, The University of New South Wales, Kensington, NSW 2052, Australia
4Department of Microbiology and Infectious Diseases, The Royal Women’s Hospital, Parkville, VIC 3052, Australia
5Department of Obstetrics and Gynecology, Murdoch Children's Research Institute, University of Melbourne, Parkville, VIC 3010, Australia
6Department of Surgery, Princess Alexandra Hospital, The University of Queensland, St Lucia, QLD 4072, Australia
7Department of Surgery, Prince of Wales Hospital Clinical School, The University of New South Wales, Kensington, NSW 2052, Australia

Received 15 January 2014; Revised 9 April 2014; Accepted 11 April 2014; Published 28 April 2014

Academic Editor: Paul Magnus Schneider

Copyright © 2014 Surabhi S. Liyanage et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Ferlay, H. Shin, F. Bray, D. Forman, C. Mathers, and D. Parkin, GLOBOCAN 2008: Cancer Incidence and Mortality Worldwide, IARC Cancer Base No. 10, International Agency for Research on Cancer, Lyon, France, 2010.
  2. S. Mudan and J. Kang, “Epidemiology and clinical presentation in esophageal cancer,” in Carcinoma of the Esophagus, S. Rankin, Ed., pp. 1–10, Cambridge University Press, New York, NY, USA, 2008. View at Google Scholar
  3. A. Jemal, M. M. Center, C. DeSantis, and E. M. Ward, “Global patterns of cancer incidence and mortality rates and trends,” Cancer Epidemiology Biomarkers and Prevention, vol. 19, no. 8, pp. 1893–1907, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. R. Holmes and T. Vaughn, “Epidemiology and pathogenesis of esophageal cancer,” Seminars in Radiation Oncology, vol. 17, pp. 2–9, 2006. View at Google Scholar
  5. M. Curado, B. Edwards, H. Shin et al., Cancer Incidence in Five Continents, vol. 9, International Agency for Research on Cancer, Lyon, France, 2007.
  6. K. Syrjänen, “HPV and oesophageal carcinoma,” in Papillomavirus Research: From Natural History to Vaccines and Beyond, M. S. Campo, Ed., pp. 229–253, Caister Academic Press, Norfolk, UK, 2006. View at Google Scholar
  7. K. Syrjänen, “HPV infections and oesophageal cancer,” Journal of Clinical Pathology, vol. 55, no. 10, pp. 721–728, 2002. View at Publisher · View at Google Scholar
  8. J. Ferlay, H. R. Shin, F. Bray, D. Forman, C. Mathers, and D. M. Parkin, “Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008,” International Journal of Cancer, vol. 127, no. 12, pp. 2893–2917, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. L. S. Engel, W. Chow, T. L. Vaughan et al., “Population attributable risks of esophageal and gastric cancers,” Journal of the National Cancer Institute, vol. 95, no. 18, pp. 1404–1413, 2003. View at Google Scholar · View at Scopus
  10. W. Blot, J. McLaughlin, and J. Fraumeni, “Esophageal cancer,” in Cancer Epidemiology and Prevention, D. Schottenfeld and J. Fraumeni, Eds., pp. 697–706, Oxford University Press, Oxford, UK, 3rd edition, 2006. View at Google Scholar
  11. A. Ghavamzadeh, A. Moussavi, M. Jahani, M. Rastegarpanah, and M. Iravani, “Esophageal cancer in Iran,” Seminars in Oncology, vol. 28, no. 2, pp. 153–157, 2001. View at Google Scholar · View at Scopus
  12. F. Islami, P. Boffetta, J.-S. Ren, L. Pedoeim, D. Khatib, and F. Kamangar, “High-temperature beverages and foods and esophageal cancer risk—a systematic review,” International Journal of Cancer, vol. 125, no. 3, pp. 491–524, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. C. Bosetti, C. La Vecchia, R. Talamini et al., “Food groups and risk of squamous cell esophageal cancer in northern Italy,” International Journal of Cancer, vol. 87, no. 2, pp. 289–294, 2000. View at Publisher · View at Google Scholar
  14. G. Launoy, C. Milan, N. E. Day, M. P. Pienkowski, M. Gignoux, and J. Faivre, “Diet and squamous-cell cancer of the oesophagus: a French multicentre case-control study,” International Journal of Cancer, vol. 76, no. 1, pp. 7–12, 1998. View at Publisher · View at Google Scholar
  15. E. Ward, “Occupational diseases and injury—esophageal cancer,” in Preventing Occupational Disease and Injury, B. Levy, G. Wagner, K. Rest, and J. Weeks, Eds., pp. 195–196, American Public Health Association, Washington, DC, USA, 2nd edition, 2005. View at Google Scholar
  16. IARC, IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, World Health Organisation and International Agency for Research on Cancer, 2007.
  17. K. Syrjanen, S. Pyrhonen, S. Aukee, and E. Koskela, “Squamous cell papilloma of the oesophagus: a tumour probably caused by human papilloma virus (HPV),” Diagnostic Histopathology, vol. 5, no. 4, pp. 291–296, 1982. View at Google Scholar · View at Scopus
  18. J. J. Hille, K. A. Margolius, S. Markowitz, and C. Isaacson, “Human papillomavirus infection related to oesophageal carcinoma in black South Africans. A preliminary study,” South African Medical Journal, vol. 69, no. 7, pp. 417–420, 1986. View at Google Scholar · View at Scopus
  19. M. Mori, R. Shimono, T. Inoue, H. Kuwano, K. Sugimachi, and R. G. Zhang, “Papillomavirus and esophageal cancer in the Japanese and Chinese,” The American Journal of Gastroenterology, vol. 84, no. 9, pp. 1126–1127, 1989. View at Google Scholar · View at Scopus
  20. S. S. Liyanage, E. Segelov, S. M. Garland et al., “The role of human papillomaviruses in esophageal squamous cell carcinoma,” Asia-Pacific Journal of Clinical Oncology, vol. 9, pp. 12–28, 2012. View at Google Scholar
  21. S. S. Liyanage, B. Rahman, I. Ridda et al., “The aetiological role of human papillomavirus in oesophageal squamous cell carcinoma: a meta-analysis,” PLoS ONE, vol. 8, no. 7, Article ID e69238, 2013. View at Publisher · View at Google Scholar
  22. A. Antonsson, D. J. Nancarrow, I. S. Brown et al., “High-risk human papillomavirus in esophageal squamous cell carcinoma,” Cancer Epidemiology Biomarkers and Prevention, vol. 19, no. 8, pp. 2080–2087, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. J. K. Kulski, T. Demeter, S. Mutavdzic, G. F. Sterrett, K. M. Mitchell, and E. C. Pixley, “Survey of histologic specimens of human cancer for human papillomavirus types 6/11/16/18 by filter in situ hybridization,” The American Journal of Clinical Pathology, vol. 94, no. 5, pp. 566–570, 1990. View at Google Scholar · View at Scopus
  24. J. Kulski, T. Demeter, G. F. Sterrett, and K. B. Shilkin, “Human papilloma virus DNA in oesophageal carcinoma,” The Lancet, vol. 2, no. 8508, pp. 683–684, 1986. View at Google Scholar · View at Scopus
  25. S. E. Tan, S. M. Garland, A. R. Rumbold, and S. N. Tabrizi, “Comparison of the INNO-LiPA and PapType assays for detection of human papillomavirus in archival vulva dysplasia and/or neoplasia tissue biopsy specimens,” Journal of Clinical Microbiology, vol. 49, no. 11, pp. 3980–3982, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. S. E. Tan, S. M. Garland, A. R. Rumbold, and S. N. Tabrizi, “Human papillomavirus genotyping using archival vulval dysplastic or neoplastic biopsy tissues: comparison between the INNO-LiPA and linear array assays,” Journal of Clinical Microbiology, vol. 48, no. 4, pp. 1458–1460, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. D. van Hamont, M. A. P. C. van Ham, J. M. J. E. Bakkers, L. F. A. G. Massuger, and W. J. G. Melchers, “Evaluation of the SPF10-INNO LiPA human papillomavirus (HPV) genotyping test and the roche linear array HPV genotyping test,” Journal of Clinical Microbiology, vol. 44, no. 9, pp. 3122–3129, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. P. E. Gravitt, C. L. Peyton, T. Q. Alessi et al., “Improved amplification of genital human papillomaviruses,” Journal of Clinical Microbiology, vol. 38, no. 1, pp. 357–361, 2000. View at Google Scholar · View at Scopus
  29. J. Layton-Henry, J. Scurry, R. Planner et al., “Cervical adenoid basal carcinoma, five cases and literature review,” International Journal of Gynecological Cancer, vol. 6, no. 3, pp. 193–199, 1996. View at Publisher · View at Google Scholar · View at Scopus
  30. M. P. Stevens, S. M. Garland, and S. N. Tabrizi, “Validation of an automated detection platform for use with the Roche Linear Array human papillomavirus genotyping test,” Journal of Clinical Microbiology, vol. 46, no. 11, pp. 3813–3816, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. M. P. Stevens, S. M. Garland, and S. N. Tabrizi, “Human papillomavirus genotyping using a modified linear array detection protocol,” Journal of Virological Methods, vol. 135, no. 1, pp. 124–126, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. S. N. Tabrizi, M. Stevens, S. Chen, E. Rudland, J. R. Kornegay, and S. M. Garland, “Evaluation of a modified reverse line blot assay for detection and typing of human papillomavirus,” American Journal of Clinical Pathology, vol. 123, no. 6, pp. 896–899, 2005. View at Publisher · View at Google Scholar · View at Scopus
  33. Epi Info, Centres for Disease Control and Prevention (CDC), 3.5.3 edition, 2011.
  34. P. D. Allison, Logistic Regression Using the SAS System: Theory and Application, SAS Institute, Cary, NC, USA, 2012.
  35. S. M. Garland, S. N. Tabrizi, E. Segelov, D. E. Dwyer, and P. J. Crowe, “High-risk human papillomavirus in esophageal squamous cell carcinoma—letter,” Cancer Epidemiology Biomarkers and Prevention, vol. 20, no. 2, article 408, 2011. View at Publisher · View at Google Scholar · View at Scopus
  36. G. Astori, S. Merluzzi, A. Arzese et al., “Detection of human papillomavirus DNA and p53 gene mutations in esophageal cancer samples and adjacent normal mucosa,” Digestion, vol. 64, no. 1, pp. 9–14, 2001. View at Publisher · View at Google Scholar · View at Scopus
  37. E. de Villiers, K. Gunst, H. Stein, and H. Scherübl, “Esophageal squamous cell cancer in patients with head and neck cancer: prevalence of human papillomavirus DNA sequences,” International Journal of Cancer, vol. 109, no. 2, pp. 253–258, 2004. View at Publisher · View at Google Scholar · View at Scopus
  38. P. O. Fidalgo, M. L. Cravo, P. P. Chaves, C. N. Leito, and F. C. Mira, “High prevalence of human papillomavirus in squamous cell carcinoma and matched normal esophageal mucosa. Assessment by polymerase chain reaction,” Cancer, vol. 76, no. 9, pp. 1522–1528, 1995. View at Publisher · View at Google Scholar
  39. B. A. Miller, M. Davidson, D. Myerson et al., “Human papillomavirus type 16 DNA in esophageal carcinomas from Alaska natives,” International Journal of Cancer, vol. 71, no. 2, pp. 218–222, 1997. View at Publisher · View at Google Scholar
  40. B. Cao, X. Tian, Y. Li et al., “LMP7/TAP2 gene polymorphisms and HPV infection in esophageal carcinoma patients from a high incidence area in China,” Carcinogenesis, vol. 26, no. 7, pp. 1280–1284, 2005. View at Publisher · View at Google Scholar · View at Scopus